Hiroki Ishihara
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 5%
- Molecular Biology
- Surgery top 10%
- Organic Chemistry top 10%
- Co-authors
- Toshio TakagiKazuhiko YoshidaJunpei IizukaTsunenori KondoKazunari TanabeHirohito KobayashiHironori FukudaHidekazu Tachibana
- Topics
- Renal cell carcinoma treatment (85 papers)Cancer Immunotherapy and Biomarkers (42 papers)Bladder and Urothelial Cancer Treatments (36 papers)
- Partner nations
- JapanUnited StatesSingapore
In The Last Decade
Hiroki Ishihara
163 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 127
- Pulmonary and Respiratory Medicine 725
- Oncology 609
- Molecular Biology 399
- Surgery 343
- Organic Chemistry 311
Countries citing papers authored by Hiroki Ishihara
This map shows the geographic impact of Hiroki Ishihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Ishihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Ishihara more than expected).
Fields of papers citing papers by Hiroki Ishihara
This network shows the impact of papers produced by Hiroki Ishihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Ishihara. The network helps show where Hiroki Ishihara may publish in the future.
Co-authorship network of co-authors of Hiroki Ishihara
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Ishihara. A scholar is included among the top collaborators of Hiroki Ishihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Ishihara. Hiroki Ishihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 7 | |
| 5 | 1 | |
| 6 | 5 | |
| 7 | 10 | |
| 8 | 1 | |
| 9 | 1 | |
| 10 | 7 | |
| 11 | 3 | |
| 12 | 10 | |
| 13 | 14 | |
| 14 | 9 | |
| 15 | 5 | |
| 16 | 12 | |
| 17 | 81 | |
| 18 | 14 | |
| 19 | 16 | |
| 20 | 11 |
About Hiroki Ishihara
Hiroki Ishihara is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 174 papers that have together received 1.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (85 papers), Cancer Immunotherapy and Biomarkers (42 papers) and Bladder and Urothelial Cancer Treatments (36 papers). The work is most often cited by research in Oncology (609 citations), Pulmonary and Respiratory Medicine (725 citations) and Geriatrics and Gerontology (59 citations). Hiroki Ishihara has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Toshio Takagi, Kazuhiko Yoshida, Junpei Iizuka, Tsunenori Kondo, Kazunari Tanabe, Hirohito Kobayashi, Hironori Fukuda, Kazunari Tanabe, Hidekazu Tachibana and Kenji Omae. Their work appears in journals such as Journal of the American College of Cardiology, PLoS ONE and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.